Androgen receptor mediates the reduced tumor growth, enhanced androgen responsiveness, and selected target gene transactivation in a human prostate cancer cell line

Cancer Research

Volumn 61, Issue 19, 2001, Pages 7310-7317

  Cinar, Bekir ^a   Koeneman, Kenneth S ^b   Edlund, Magnus ^a   Prins, Gail S ^c   Zhau, Haiyen E ^a   Chung, Leland W K ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; GLUCOCORTICOID; PLASMID DNA; PROSTATE SPECIFIC ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENICITY; CELL ADHESION; CELL DIFFERENTIATION; CELL INVASION; CONTROLLED STUDY; GENE TARGETING; GROWTH REGULATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION;

ANDROGENS; ANIMALS; CELL ADHESION; CELL DIVISION; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; METRIBOLONE; MICE; MICE, NUDE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TESTOSTERONE CONGENERS; TRANS-ACTIVATION (GENETICS); TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0035477330     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Deletion of the steroid-binding domain of the human androgen receptor gene in one family with complete androgen insensitivity syndrome: Evidence for further genetic heterogeneity in this syndrome
2. Control of steroid hormone receptor action
3. Molecular basis of androgen receptor diseases
4. Steroid hormone receptors: Many actors in search of a plot
5. The nuclear receptor superfamily: The second decade
6. Nuclear receptors: Structure, function and involvement in disease
7. A consensus DNA-binding site for the androgen receptor
8. Control of transcription by steroid hormones
9. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action
10. Coactivators and corepressors as mediators of nuclear receptor function: An update
11. Transcriptional regulation of the steroid receptor genes
12. Chromatin remodeling and transcription
13. Hormone action and chromatin remodeling
14. Prostate epithelial differentiation is dictated by its surrounding stroma
15. The role of stromal cells in prostate cancer development and progression
16. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium
17. Stromal cell oxidation: A mechanism by which tumors obtain vitamin C
18. Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer
19. Characterization of nerve growth factor precursor protein expression by human prostate stromal cells: A role in selective neurotrophin stimulation of prostate epithelial cell growth
20. Interaction between stromal cells and tumor cells induces chemoresistance and matrix metalloproteinase secretion
21. Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells
22. Integrin expression and usage by prostate cancer cell line on laminin substrate
23. Malignant transformation of human prostatic epithelium is associated with the loss of androgen receptor immunoreactivity in the surrounding stroma
24. Expression of androgen receptor coregulatory proteins in prostate cancer and stromal-cell culture models
25. Androgen receptor expression in prostate carcinoma cells suppresses α6β4 integrin-mediated invasive phenotype
26. The human androgen receptor: Complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate
27. Cloning of human androgen receptor complementary DNA and localization to the X chromosome
28. Synthesis and post-translational modification of the androgen receptor in LNCaP cells
29. In vitro translation of androgen receptor cRNA results in an activated androgen receptor protein
30. Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones
31. Androgen receptor phosphorylation
32. Androgen receptor localization and turnover in human prostate epithelium treated with the antiandrogen, casodex
33. Steroid requirement for androgen receptor dimerization and DNA binding. Modulation by intramolecular interactions between the NH2-terminal and steroid-binding domains
34. Androgen-regulated gene expression in prostate cancer
35. 6-kb promoter fragment mimics in transgenic mice the prostate-specific and androgen-regulated expression of the endogenous prostate-specific antigen gene in humans
36. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter
37. Intermolecular NH2-/carboxyl-terminal interactions in androgen receptor dimerization revealed by mutations that cause androgen insensitivity
38. Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells. LNCaP, by dihydrotestosterone
39. Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaP
40. Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor
41. Regulation of androgen-dependent prostatic cancer cell growth: Androgen regulation of CDK2, CDK4, and CKI p16 genes
42. Control of the proliferation of prostate cancer cells by an androgen and two antiandrogens. Cell specific sets of responses
43. Hormonal regulation of the androgen receptor expression in human prostatic cells in culture
44. In vivo amplification of the androgen receptor gene and progression of human prostate cancer
45. Androgen receptor gene amplification: A possible molecular mechanism for androgen deprivation therapy failure in prostate cancer
46. A mechanism for hormone-independent prostate, cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase
47. Prostate cancer: Molecular biology of early progression to androgen independence
48. Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways
49. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer
50. LNCaP progression model of human prostate cancer: Androgen-independence and osseous metastasis
51. Prostate cancer progression, metastasis, and gene expression in transgenic mice
52. Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes
53. Androgen-repressed phenotype in human prostate cancer
54. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts
55. Both androgen receptor and glucocorticoid receptor are able to induce prostate-specific antigen expression, but differ in their growth-stimulating properties of LNCaP cells
56. Identification and characterization of estrogen receptor variants in prostate cancer cell lines
57. Delayed apoptotic responses associated with radiation-induced neoplastic transformation of human hybrid cells
58. Requirement of the integrin β 3 subunit for carcinoma cell spreading or migration on vitronectin and fibrinogen
59. Immunostaining for prostate cancer androgen receptor in paraffin identifies a subset of men with a poor prognosis
60. A model for hormone receptor binding to mouse mammary tumor virus regulatory element based on hydroxy radical foot-printing
61. Regions of prostate-specific antigen (PSA) promoter confer androgen-independent expression of PSA in prostate cancer cells
62. Rho GTPases. Signaling, migration, and invasion
63. Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: Role of bone stromal cells
64. Genetic and epigenetic influences in prostatic carcinogenesis
65. Suppression of tumorigenicity in the human prostate cancer cell line M12 via microcell-mediated restoration of chromosome 19
66. Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotides
67. Isolation and characterization of a novel epithelium-specific transcription factor, ESE-1, a member of the ets family
68. Characterization of ESE-2, a novel ESE-1-related ets transcription factor that is restricted to glandular epithelium and differentiated keratinocytes
69. ESE-3, a novel member of an epithelium-specific ets transcription factor subfamily, demonstrates different target gene specificity from ESE-1
70. PDEF, a novel prostate epithelium-specific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression